The human endometrium is a dynamic tissue that undergoes cyclic changes under the influence of steroid hormones as well as numerous local paracrine and autocrine factors. Heat shock 70 kDa protein (HSPA5; also known as GRP78/BiP), a molecular chaperone within the endoplasmic reticulum, plays crucial roles in normal cellular processes as well as in stress conditions, in which it is a central regulator for the unfolded protein response (UPR). We hypothesized that HSPA5 expression level is variable throughout the menstrual cycle in human endometrium and that estrogen signaling cross-talks with UPR signaling by interacting with HSPA5. HSPA5 expression throughout the menstrual cycle was evaluated in vivo in normal human endometrium. Using in vitro techniques, we then assessed the bidirectional regulation of HSPA5 and estrogen signaling in human endometrial glandular (Ishikawa) and stromal cells (ESC). HSPA5 immunoreactivity in endometrial glandular and stromal cells was cycle-dependent, and was significantly higher in phases of the menstrual cycle when estradiol (E 2 ) levels are known to be the lowest compared with the rest of the cycle (P , 0.001). E 2 did not affect HSPA5 expression after 8-24 h incubation in Ishikawa cells and ESC in vitro. However, tunicamycin-induced HSPA5 expression was significantly lowered in these cells when pretreated with E 2 (P , 0.01 and P , 0.05, respectively). On the other hand, tunicamycin decreased E 2 up-regulated alkaline phosphatase activity (P , 0.001). In conclusion, there is cycle-dependent HSPA5 expression with a possible inverse correlation between HSPA5 expression and E 2 levels in human endometrium. We suggest that estrogen signaling cross-talks with the UPR cascade by interacting with HSPA5, as supported by our in vitro findings. endometrium, endoplasmic reticulum stress, estrogen, HSPA5 (GRP78/BiP), unfolded protein response
INTRODUCTION
The human endometrium is a dynamic tissue that undergoes cyclic changes to control tissue differentiation, proliferation, apoptosis, and angiogenesis under the influence of estrogen and progesterone, as well as numerous local paracrine and autocrine factors, during each menstrual cycle [1] . Estradiol (E 2 ) exerts its effects by classical (genomic) mechanisms-that is, binding to estrogen receptors to regulate transcription [2] or by nonclasical (nongenomic) mechanisms-that is, binding to receptors located at the cell membrane, mitochondria, and the endoplasmic reticulum (ER) [3, 4] .
Heat shock 70 kDa protein 5 (HSPA5), also known as glucose-regulated protein (GRP78) or immunoglobulin heavy chain-binding protein (BiP), is a member of the heat shock 70 class of proteins (HSP70) [5, 6] and resides within the ER, where it functions as a Ca 2þ -dependent molecular chaperone that facilitates proper protein folding, maintains proteins in a folded state, and prevents protein folding intermediates from aggregating [7] . Overloading of ER with proteins, hypoxia, oxidative stress, alterations in Ca 2þ homeostasis, and glucose deprivation causes ER stress due to the accumulation of misfolded or unfolded proteins, and triggers an evolutionarily conserved mechanism called the unfolded protein response (UPR) to cope with the stress condition [8] . In nonstressed cells, HSPA5 binds to the luminal domains of three ERresident transmembrane proteins: endoplasmic reticulum to nucleus signaling 1 (ERN1), eukaryotic translation initiation factor 2-alpha kinase 3, and activating transcription factor 6. Upon ER stress, these proteins are released from HSPA5, become activated, and act as transducers of UPR by inducing signal-transduction events that aim to ameliorate the accumulation of misfolded proteins in the ER and protect the cell against ER stress-induced cell death [7] [8] [9] . However, when the primary stimulus causing ER stress is severe or prolonged, cell death is induced, typically by apoptosis [10] [11] [12] .
Expression of HSP70 has been shown to be correlated with sex steroid receptors, and their amounts are known to exhibit menstrual cycle-dependent changes in human endometrium [13, 14] . As a member of the HSP70 protein family, HSPA5 expression is tightly regulated at the site of embryo implantation in mice [15] . However, the regulation and possible roles of HSPA5 in human endometrium is uncertain. With the given information, we hypothesized that HSPA5 expression level is menstrual cycle-dependent in human endometrium and that estrogen signaling cross-talks with UPR signaling by interacting with HSPA5. To test this hypothesis, we investigated the in vivo expression of HSPA5 in human endometrium throughout the menstrual cycle using immunohistochemistry and the bidirectional regulation of HSPA5 and estrogen signaling in human endometrial glandular (Ishikawa) and stromal cells (ESC) in culture using Western blot analysis, immunocytochemistry, cell proliferation assay, and alkaline phosphatase activity assay, a well-known estrogenicity assay.
MATERIALS AND METHODS

Tissue Collection
For immunohistochemical studies, endometrial tissues were obtained from 38 cycles undergoing laparoscopy or hysterectomy for benign gynecological conditions other than endometrial disease. The day of the menstrual cycle was established from the women's menstrual history and was confirmed by endometrial histology using the criteria of Noyes et al. [16] . Endometrial samples were grouped according to menstrual cycle phase: early (Days 1-5; n ¼ 7), mid-(Days 6-10; n ¼ 8), and late (Days 11-14; n ¼ 5) proliferative phase, and early (Days 15-18; n ¼ 8), mid-(Days 19-23; n ¼ 6) and late (Days 24-28; n ¼ 4) secretory phase.
For ESC cultures, endometrial samples (n ¼ 3 from midproliferative phase and n ¼ 3 from early secretory phase) were obtained at the time of hysterectomy or laparoscopy from fertile women (mean age, 38.5 yr; range, 32-42 yr) who did not receive any hormonal medications in the preceding 3 mo. The endometrial samples were placed in Hanks balanced salt solution and transported to the laboratory for ESC isolation and long-term culture.
Written, informed consent was obtained from each patient before surgery using consent forms. The protocols were approved by the Human Investigation Committee of Yale University.
Immunohistochemistry
Formalin-fixed paraffin-embedded samples were cut into 5-lm sections. After deparaffinization and rehydration, slides were rinsed with tris-buffered saline (TBS; 20 mM Tris, 150 mM NaCl, pH 7.6) and boiled in 10 mM citrate buffer, pH 6.0, for antigen retrieval three times for 5 min. Sections were then immersed in 3% hydrogen peroxide for 15 min to quench endogenous peroxidase activity, washed in TBS twice, and incubated in a humidified chamber with 5% normal goat serum to block nonspecific binding (Vector Laboratories, Burlingame, CA) in TBS containing 0.1% Tween 20 (TBS-T) for 30 min at room temperature. After removing excess serum, the sections were incubated with rabbit monoclonal anti-human HSPA5 antibody (1:200; Cell Signaling Technology, Beverly, MA) overnight at 48C in a humidified chamber. For negative controls, normal rabbit immunoglobulin G was used at the same concentration. Sections were washed three times for 5 min with TBS, and then goat biotinylated anti-rabbit antibody (1:400; Vector Laboratories) was added for 30 min at room temperature. The antigen-antibody complex was detected with a streptavidin-biotin-peroxidase kit (Vector Laboratories). 3,3-Diaminobenzidine tetrahydrochloride dihydrate (Vector Laboratories) was used as the chromogen, and sections were slightly counterstained with hematoxylin and mounted with Permount (Fisher Chemicals, Springfield, NJ).
The intensity of HSPA5 immunostaining was semiquantitatively evaluated by the following categories: 0 (no staining), 1þ (weak, but detectable staining), 2þ (moderate or distinct staining), and 3þ (intense staining). For each slide, a histological score (HSCORE) value was derived by summing the percentage of cells that stained at each intensity category and multiplying that value by the weighted intensity of the staining, using the formula HSCORE ¼ R P i (i þ 1), where i represents the intensity score, and P i is the corresponding percentage of the cells. In each slide, five randomly selected areas were evaluated under a light microscope, and the percentage of the cells at the various intensities within these areas was determined at different times by two investigators in a blind fashion. The intraindividual and interindividual coefficients of variation were 10% and 12%, respectively, for the HSCORE evaluation. The average score of the two investigators was used.
Isolation and Culture of Human ESC
ESC were separated and maintained in monolayer culture as described previously [17] . Briefly, endometrial tissues were minced with a sterile surgical blade and digested in Hanks balanced salt solution (Sigma-Aldrich, St. Louis, MO) containing collagenase B (1 mg/ml, 15 units (U)/mg; Roche, Indianapolis, IN), deoxyribonuclease I (0.1 mg/ml, 1500 U/mg; Roche), penicillin (200 U/ ml), and streptomycin (200 mg/ml) for 60 min at 378C with agitation. The dispersed endometrial cells were separated by filtration through a wire sieve (73-lm diameter pore; Sigma-Aldrich) and cultured in Dulbecco modified Eagle medium (DMEM) Ham F-12 (1:1 vol/vol; Sigma-Aldrich) containing 10% vol/vol fetal bovine serum (Invitrogen, Carlsbad, CA) and 1% vol/vol antibiotics-antimycotics (Life Technologies, Rockville, MD). The cultures were maintained in a standard 95% air/5% CO 2 incubator at 378C until grown to confluence (7-10 days).
Experimental Setup
After the first passage, ESC were first assayed using specific cell surface markers and were found to contain 0%-7% epithelial cells, no detectable endothelial cells, and 0.2% macrophages [18, 19] . Then, Ishikawa cells (a welldifferentiated endometrial adenocarcinoma cell line, kindly provided by Dr. R. Hochberg, Yale University School of Medicine, New Haven, CT) and ESC were plated in 60-mm culture dishes and grown to confluence. In all the experiments, Ishikawa cells and ESC were preincubated with serum-free, phenol red-free DMEM Ham F12 for 24 h. All the experiments were repeated on at least three different occasions; for ESC experiments, this was done using cells obtained from at least three different patients.
Confluent Ishikawa cells and ESC in 60-mm culture dishes were incubated with vehicle or 10 À8 M E 2 (Sigma-Aldrich) for 8 h and 24 h. At the end of the treatment period, the medium was removed and the cells were washed with cold TBS and immediately transferred to À808C until processed for analysis of HSPA5 expression by Western blot.
In another experimental setup, confluent cell cultures were incubated with vehicle (control) or 10
À8 M E 2 in media containing 2% charcoal-stripped serum for 5 days. Thereafter, Ishikawa cells and ESC were incubated in serum-free phenol red-free media for 24 h. Then, cells were treated with 4 lg/ml tunicamycin (Sigma-Aldrich), a common agent used to induce ER stress [20] , for 4 h and 8 h. At the end of the treatment period, the medium was removed and the cells were washed with cold TBS and immediately transferred to À808C until processed for analysis of HSPA5 expression by Western blot.
For alkaline phosphatase assays and 3-(4,5-dimethylthiazol3-yl)-2,5-diphenyltetrazolium bromide (MTT) cell proliferation assays, preconfluent Ishikawa cells in 96-well plates were incubated with vehicle or 4 lg/ml tunicamycin for 4 h. Then all the wells were washed with PBS (catalog no. 14190144; GIBCO/Invitrogen), and the cells were treated with 10
À8 M E 2 for 72 h. Treatment with E 2 was repeated at 36 h. The experiments in 96-well plates were conducted using replicates of 8-wells per treatment condition and repeated at least three times.
Western Blot Analysis
Total protein extraction and Western blot analysis was performed as previously described [4] . After PAGE and protein blotting, the membrane was blocked with 5% nonfat dry milk in TBS-T for 1 h to reduce nonspecific binding. Subsequently, the membrane was incubated with rabbit monoclonal anti-human HSPA5 primary antibody (diluted 1:1000 dilution with 5% bovine serum albumin in TBS-T; Cell Signaling Technology) overnight at 48C. The membrane was washed with TBS-T for 15 min, incubated with goat horseradish peroxidase-conjugated anti-rabbit secondary antibody (diluted 1:5000 in TBS-T; Vector Laboratories), and then washed again. The protein was visualized by light emission on film (Denville Scientific, Metuchen, NJ) with a chemiluminescence kit (Amersham Biosciences, Piscataway, NJ). After stripping, the membranes were reprobed with mouse HRP-conjugated b-actin primary antibody (1:50 000; Santa Cruz Biotechnology, Santa Cruz, CA). The membrane was washed with TBS-T for 30 min. The protein was visualized by light emission on film (Denville Scientific) with a chemiluminescence kit (Amersham Biosciences). Band intensities were quantified using computer densitometry analysis (ImageJ; National Institutes of Health, Bethesda, MD) and normalized to b-actin readings.
Immunocytochemistry
For immunocytochemistry, Ishikawa cells and ESC were plated on fourchamber slides (Falcon, Franklin Lakes, NJ). Confluent cells were treated with vehicle (control) or 2 lg/ml tunicamycin alone for 8 h or with 10
À8 M E 2 for 5 days prior to tunicamycin treatment. Treated cells were fixed with 4% paraformaldehyde at 48C for 30 min and then washed with TBS. Cells were permeabilized within TBS-T for 5 min at room temperature. Immunocytochemical analysis of Ishikawa cells, including HSCORE evaluation, was performed according to the protocol used for immunohistochemistry, starting from the quenching step of endogenous peroxidase activity. For the immunocytochemical analysis of ESC, the streptavidin alkaline phosphatase technique was applied. After incubation with primary and then secondary antibody, cells were incubated with streptavidin-alkaline phosphatase complex for 30 min (Lab Vision, Fremont, CA). Subsequently, slides were rinsed three times in TBS and incubated with Fast Red (Vector Laboratories) for 10 min. Slides were lightly counterstained with hematoxylin before permanent mounting.
Alkaline Phosphatase Assay
To bioassay the estrogenic potency, we used a well-developed technique employing induction of alkaline phosphatase activity in Ishikawa cells [21] . This technique is based on a colorimetric assay of alkaline phosphatase enzyme activity in 96-well microtiter plates. Alkaline phosphatase activity was measured exactly as described [21] .
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MTT Cell Proliferation Assay for Ishikawa Cells in Culture
Cell proliferation was assessed by a colorimetric assay using MTT. This assay detects the formation of dark blue formazan product from MTT in active mitochondria and was performed as described previously [22] . Briefly, cells were grown in 96-well plates, and 4 h before the end of each experiment, 10 ll of MTT solution was added onto each well. The optical absorbance at 570 nm was read within 30 min with a microplate reader (Thermomax, Menlo Park, CA). Data are expressed in optic density units. The last column of each 96-well plate contained only media without cells and was used as a negative control.
Statistical Analysis
HSCORE values of immunohistochemistry and immunocytochemistry analyses as well as data from Western blots, alkaline phosphatase activity assays, and MTT assays were normally distributed as determined by the Kolmogorov-Smirnov test and, therefore, were analyzed with one-way ANOVA followed by post hoc Holm-Sidak testing. Statistical calculations were performed using Sigma Stat for Windows, version 3.0 (Jandel Scientific, San Rafael, CA); P , 0.05 was considered to be significant.
RESULTS
Expression of HSPA5 in Human Endometrium Throughout the Menstrual Cycle
Human endometrial tissues were subjected to immunohistochemical staining for HSPA5 expression. HSPA5 staining was cytoplasmic and showed menstrual cycle-dependent changes in both glandular and stromal cells (Figs. 1 and 2) . Endometrial glandular cells exhibited moderate to strong immunostaining, whereas ESC showed weak to moderate staining. HSCORE analysis indicated that HSPA5 immunoreactivity in endometrial glandular cells in the early proliferative, early secretory and late secretory phases was significantly higher than in the midproliferative, late proliferative, and midsecretory phases (P , 0.001; Figs. 1 and 2 ). In ESC, HSPA5 expression was significantly higher in the late secretory phase compared to all other cycle phases, except for the early proliferative phase (P , 0.001; Figs. 1 and 2) . Moreover, stromal cells in the early proliferative phase showed higher immunostaining compared to the late proliferative and midsecretory phases (P , 0.001; Figs. 1 and 2 ).
In Vitro Regulation of HSPA5 Expression in Ishikawa Cells and ESC
To investigate the effect of E 2 on HSPA5 expression level, cultured Ishikawa cells and ESC were treated with vehicle or 10 À8 M E 2 for 8 h and 24 h and analyzed by Western blot. Neither Ishikawa cells nor ESC treated with E 2 showed significant changes in HSPA5 expression at both time periods analyzed (Fig. 3) .
Long-Term E 2 Treatment Decreases Tunicamycin-Induced HSPA5 Expression in Ishikawa Cells in Culture
To investigate the effect of E 2 on HSPA5 expression in tunicamycin-treated cells, cultured Ishikawa cells and ESC from normal endometrium were treated with vehicle or 10 À8 M E 2 for 5 days prior to 4-lg/ml tunicamycin treatment for 4 h and 8 h, which were then analyzed by Western blots (Fig. 4) . In Ishikawa cells, HSPA5 levels significantly increased following tunicamycin treatment for 4 h and 8 h compared to control (P , 0.01; Fig. 4) , and tunicamycin-induced HSPA5 expression was significantly lowered when cells were previously treated with E 2 (P , 0.01; Fig. 4) .
Although no significant difference in HSPA5 expression among the treatments were observed after 4 h in ESC, tunicamycin increased HSPA5 expression significantly compared to control following 8 h of treatment (P , 0.05; Fig. 5 ). However, long-term E 2 incubation prior to tunicamycin treatment significantly reduced the effect of tunicamycin on HSPA5 expression in ESC at 8 h (P , 0.05; Fig. 5 ).
To confirm the attenuating effect of E2 on tunicamycininduced HSPA5 expression, Ishikawa cells and ESC incubated with or without E 2 for 5 days on tissue chamber slides were treated with 2 lg/ml tunicamycin for 8 h and cells were then analyzed by immunocytochemistry. Cytoplasmic localization 
HSPA5-ESTROGEN INTERACTION IN HUMAN ENDOMETRIUM
123 of HSPA5 was revealed in both cell types (Fig. 6, A-C and E-G) in culture, in agreement with the in vivo results. HSCORE analysis revealed a significant increase in HSPA5 immunoreactivity in the Ishikawa cells and ESC treated with tunicamycin compared to vehicle-treated cells (P , 0.001; Fig. 6, A, B, I , and E, F, J). However, preincubation of Ishikawa cells and ESC with E 2 significantly lowered the effect of tunicamycin on HSPA5 expression in these cells (P , 0.001; Fig. 6, B, C, I , and F, G, J).
The Effect of Tunicamycin on the Estrogenicity of Ishikawa Cells
In order to evaluate the effect of increased HSPA5 expression on estrogenic action, we carried out the alkaline phosphatase assay, a well-developed and widely used technique to bioassay estrogenic responsiveness [21, 23] , in Ishikawa cells. Ishikawa cells at 80% confluency in 96-well plates were incubated with vehicle or 4-lg/ml tunicamycin for 4 h followed by 10 À8 M E 2 treatment for 72 h. The E 2 significantly induced alkaline phosphatase activity compared to control (P , 0.001; Fig. 7A ). Although cells treated with tunicamycin alone revealed no significant difference in alkaline phosphatase activity compared to control, 4-h tunicamycin treatment prior to E 2 incubation reduced E 2 -induced alkaline phosphatase activity significantly (P , 0.001; Fig. 7A ).
Effect of Tunicamycin on Ishikawa Cell Proliferation
To determine whether the reducing effect of tunicamycin on alkaline phosphatase activity in cultured Ishikawa cells is a consequence of its possible anti-proliferative action, MTT proliferation assays were performed on Ishikawa cells that were treated with the same experimental setup as the alkaline phosphatase experiment. As expected, E 2 induced Ishikawa cell proliferation compared to control (P , 0.05; Fig. 7B ). However, the presence of tunicamycin with or without E 2 had no additional effect on cell proliferation compared to control or E 2 alone (Fig. 7B) .
DISCUSSION
Ovarian steroids and numerous local paracrine and autocrine factors play crucial roles in regulating growth, differentiation, and function in the human endometrium during each menstrual cycle [1, 24] . The regulation of HSPA5 in human endometrium and its possible roles in cyclic changes of endometrial À8 M E 2 for 8-h and 24-h treatment periods. HSPA5 levels in the control cells frozen at the beginning (C0), 8 h (C8), and 24 h (C24) of the treatment period and in the E 2 -treated cells frozen at 8 h (E8) and 24 h (E24) of the treatment period are shown. Treatment with E 2 had no effect on HSPA5 expression on both cell types. M, molecular weight marker. Experiment was repeated three times with ESC using cells prepared from endometrial tissue specimens obtained from three different patients as well as with Ishikawa cells. Representative blots from one experiment are presented. Bars represent mean 6 SEM. 124 differentiation, proliferation, apoptosis, angiogenesis, and angiostasis is uncertain. In this study, cycle-dependent expression of HSPA5 in both Ishikawa cells and ESC was determined by HSCORE analysis. The highest HSPA5 expression in endometrial glandular and stromal cells was found in the early proliferative and late secretory phases, which are known to have the lowest E 2 levels. This suggests a possible direct or indirect role for E 2 signaling in the regulation of HSPA5 expression. Alternatively, increases in leukocyte accumulation and inflammatory chemokine/cytokine release during the late secretory and early proliferative phases may result in severe or prolonged ER stress, which may, in turn, result in the accumulation of an intolerable level of unfolded proteins in the ER lumen and the stimulation of HSPA5 expression through activation of sXBP1-mediated UPR signaling. Thus, a pathway that is independent of E 2 signaling is also possible. Previously, several immunohistochemical studies revealed menstrual cycle-dependent changes in the amounts of the various members of the heat shock family of proteins in human endometrium and indicated that HSPs are regulated by steroid hormones [13, 14] . Our immunohistochemical results likewise suggest an in vivo regulation of HSPA5 expression in human endometrium and confirm the previous studies given that HSPA5 is a member of the HSP70 protein family.
HSPA5 is a Ca 2þ -dependent molecular chaperone in the ER lumen where it facilitates proper protein folding, maintains proteins in a folded state, and targets unfolded and/or misfolded proteins to proteosomal degradation [7, [25] [26] [27] . It has previously been suggested that ordinary physiological dynamics of the production of exportable proteins is sufficient to induce the synthesis of HSPA5 [25] . The need for more resident ER proteins increases in parallel with an increase in the secretory workload [28] . Moreover, HSPA5 has been shown to play a role in the storage of Ca 2þ within the ER lumen and to be involved in intracellular Ca 2þ homeostasis [29] . Because intracellular Ca 2þ signals are important regulators of many cellular events, their regulation by HSPA5 could affect a wide variety of cellular processes. Although the specific function of HSPA5 in the human endometrium is not known, the presence of HSPA5 expression in both glandular and stromal cells throughout the menstrual cycle supports its Certain pathological stress conditions leading to accumulation of unfolded and/or misfolded proteins in the ER lumen produce ER stress and trigger the UPR to cope with the stress condition [8, 20] . Once UPR signaling is activated, ERN1 is released from HSPA5, and it becomes an active endonuclease, resulting in cleavage of XBP1 to sXBP1. Thereafter, the active XBP1 (sXBP1) targets the transcription of HSPA5 and other ER chaperones, resulting in an increased level of HSPA5 expression [7] [8] [9] .
Leukocytes are known to produce high levels of cytokines and reactive oxygen species, both capable of inducing the expression of HSP70 [30] . The accumulation of inflammatory leukocytes and the increase in the amount of cytokines such as tumor necrosis factor-alpha and interleukin 1 beta in human endometrium during the late secretory and early proliferative phases [31] [32] [33] [34] may induce ER stress. As discussed above, this may result in the stimulation of HSPA5 expression through activation of sXBP1-mediated UPR signaling. As a transcriptional regulator of HSPA5, sXBP1 could be the factor responsible for the highest level of HSPA5 expression observed during these phases [35, 36] .
In previous studies, HSPA5 has been shown to be induced by E 2 in the mouse uterus via an estrogen receptor-independent mechanism [37] , and the expression of HSPA5 is tightly regulated at the site of embryo implantation, an event that is regulated by estrogen in mice [15] . Moreover, in vitro experiments have shown that HSPA5 expression, which is absent in the absence of E 2 , is upregulated within 2 h and remains unchanged until 24 h after E 2 incubation in the mouse uterine stromal cells [38] . However, we observed that HSPA5 expression does not change following 8 and 24 h with or without E 2 treatment in both Ishikawa cells and ESC in vitro, suggesting that our in vivo findings are likely due to indirect effects of E 2 , rather than its direct (genomic) actions. Moreover, our in vitro experiments have also shown that the presence of E 2 significantly decreases tunicamycin-induced HSPA5 expression, suggesting an inhibitory role for E 2 on the activation of UPR signaling. This could also be an explanation for our results that show lower level of HSPA5 expression during mid-and late proliferative and midsecretory phases in vivo.
In addition to an inhibitory effect of E 2 on tunicamycinmediated activation of UPR, we further found that activation of UPR signaling could also affect estrogenic response in endometrial glandular cells as tested by an alkaline phosphatase assay. We also know that this finding is not related to the proliferative and/or antiproliferative effect of UPR and E 2 as determined by the MTT cell survival assay. With these in vitro results, we speculate that there is possible cross-talk between UPR and estrogen-signaling pathways. Because our data that support this are preliminary, further studies need to be performed to clarify this bidirectional interaction in endometrial cells.
In conclusion, we have identified cycle-dependent HSPA5 expression in human endometrium with a possible inverse correlation between HSPA5 expression and E 2 levels. Our in vitro results support the finding that E 2 likely suppresses UPR signaling in normal endometrial cells to maintain tissue growth and homeostasis. In vitro findings of this study also suggest that UPR signaling likely suppresses estrogenic responsiveness, suggesting cross-talk between E 2 and UPR cascades. Future investigations targeting HSPA5 in inflammatory and estrogenrelated endometrial diseases such as endometriosis may further help us to understand the pathogenesis of these diseases.
